JP2013537543A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013537543A5 JP2013537543A5 JP2013524350A JP2013524350A JP2013537543A5 JP 2013537543 A5 JP2013537543 A5 JP 2013537543A5 JP 2013524350 A JP2013524350 A JP 2013524350A JP 2013524350 A JP2013524350 A JP 2013524350A JP 2013537543 A5 JP2013537543 A5 JP 2013537543A5
- Authority
- JP
- Japan
- Prior art keywords
- influenza virus
- producing
- influenza
- vaccine
- cell
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102010037008.8 | 2010-08-16 | ||
| DE102010037008 | 2010-08-16 | ||
| DE102011050353 | 2011-05-13 | ||
| DE102011050353.6 | 2011-05-13 | ||
| PCT/DE2011/075194 WO2012041311A1 (de) | 2010-08-16 | 2011-08-16 | Permanente humane amniozyten zelllinie zur herstellung von influenzaviren |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013537543A JP2013537543A (ja) | 2013-10-03 |
| JP2013537543A5 true JP2013537543A5 (enExample) | 2014-09-25 |
| JP5928843B2 JP5928843B2 (ja) | 2016-06-01 |
Family
ID=44936126
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013524350A Active JP5928843B2 (ja) | 2010-08-16 | 2011-08-16 | インフルエンザウイルスを製造するための永久ヒト羊膜細胞株 |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US20130344569A1 (enExample) |
| EP (1) | EP2606128B1 (enExample) |
| JP (1) | JP5928843B2 (enExample) |
| KR (1) | KR101780257B1 (enExample) |
| CN (1) | CN103168100B (enExample) |
| AU (1) | AU2011307655B2 (enExample) |
| BR (1) | BR112013003766B1 (enExample) |
| CA (1) | CA2808453C (enExample) |
| DE (1) | DE112011102737A5 (enExample) |
| DK (1) | DK2606128T3 (enExample) |
| ES (1) | ES2524894T3 (enExample) |
| IL (1) | IL224728A (enExample) |
| MX (1) | MX337687B (enExample) |
| PL (1) | PL2606128T3 (enExample) |
| PT (1) | PT2606128E (enExample) |
| RU (1) | RU2565546C2 (enExample) |
| SG (1) | SG187863A1 (enExample) |
| TW (1) | TW201211257A (enExample) |
| WO (1) | WO2012041311A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2024537896A (ja) | 2021-10-18 | 2024-10-16 | リジェネロン・ファーマシューティカルズ・インコーポレイテッド | アデノウイルス随伴ウイルスポリヌクレオチドを含む真核細胞 |
| AR127674A1 (es) | 2021-10-18 | 2024-02-21 | Regeneron Pharma | Células de mamífero que comprenden genes cas9 integrados para producir sitios de integración estables, y células de mamífero que comprenden sitios de integración estables y otros sitios |
| CN121343924A (zh) * | 2024-07-15 | 2026-01-16 | 干细胞转化研究中心有限公司 | 极早期干细胞在流感病毒制备、检测和药物筛选中的应用 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19612966B4 (de) * | 1996-04-01 | 2009-12-10 | Novartis Vaccines And Diagnostics Gmbh & Co. Kg | MDCK-Zellen und Verfahren zur Vermehrung von Influenzaviren |
| US7410798B2 (en) * | 2001-01-10 | 2008-08-12 | Geron Corporation | Culture system for rapid expansion of human embryonic stem cells |
| US20050170463A1 (en) | 1999-04-15 | 2005-08-04 | Abraham Bout | Recombinant protein production in permanent amniocytic cells that comprise nucleic acid encoding adenovirus E1A and E1B proteins |
| US6492169B1 (en) * | 1999-05-18 | 2002-12-10 | Crucell Holland, B.V. | Complementing cell lines |
| DE19955558C2 (de) * | 1999-11-18 | 2003-03-20 | Stefan Kochanek | Permanente Amniozyten-Zelllinie, ihre Herstellung und Verwendung zur Herstellung von Gentransfervektoren |
| US7192759B1 (en) * | 1999-11-26 | 2007-03-20 | Crucell Holland B.V. | Production of vaccines |
| ES2526170T3 (es) * | 2004-12-23 | 2015-01-07 | Medimmune, Llc | Línea celular MDCK no tumorigénica para propagar virus |
| ES2402061T3 (es) * | 2005-10-17 | 2013-04-26 | Medimmune, Llc | Método de aumento de la replicación del virus influenza |
| DE102005054628A1 (de) | 2005-11-16 | 2007-05-24 | Cevec Pharmaceuticals Gmbh | Verfahren zur Herstellung von permanenten humanen Zelllinien |
| AU2007347716B2 (en) * | 2006-09-15 | 2013-06-20 | Medimmune, Llc | MDCK cell lines supporting viral growth to high titers and bioreactor process using the same |
-
2011
- 2011-08-16 JP JP2013524350A patent/JP5928843B2/ja active Active
- 2011-08-16 US US13/816,976 patent/US20130344569A1/en not_active Abandoned
- 2011-08-16 AU AU2011307655A patent/AU2011307655B2/en active Active
- 2011-08-16 EP EP11781731.2A patent/EP2606128B1/de active Active
- 2011-08-16 MX MX2013001772A patent/MX337687B/es active IP Right Grant
- 2011-08-16 BR BR112013003766-0A patent/BR112013003766B1/pt active IP Right Grant
- 2011-08-16 DK DK11781731.2T patent/DK2606128T3/en active
- 2011-08-16 RU RU2013110786/10A patent/RU2565546C2/ru active IP Right Revival
- 2011-08-16 TW TW100129162A patent/TW201211257A/zh unknown
- 2011-08-16 ES ES11781731.2T patent/ES2524894T3/es active Active
- 2011-08-16 WO PCT/DE2011/075194 patent/WO2012041311A1/de not_active Ceased
- 2011-08-16 CA CA2808453A patent/CA2808453C/en active Active
- 2011-08-16 PL PL11781731T patent/PL2606128T3/pl unknown
- 2011-08-16 SG SG2013011499A patent/SG187863A1/en unknown
- 2011-08-16 PT PT117817312T patent/PT2606128E/pt unknown
- 2011-08-16 DE DE112011102737T patent/DE112011102737A5/de not_active Withdrawn
- 2011-08-16 KR KR1020137006640A patent/KR101780257B1/ko active Active
- 2011-08-16 CN CN201180050018.7A patent/CN103168100B/zh active Active
-
2013
- 2013-02-14 IL IL224728A patent/IL224728A/en active IP Right Grant
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Lasaro et al. | New insights on adenovirus as vaccine vectors | |
| JP2012507270A5 (enExample) | ||
| ES2532015T3 (es) | Método para la producción de vectores adenovíricos | |
| WO2020076820A3 (en) | Compositions and methods for preparing viral vectors | |
| MX2024005757A (es) | Virus pichinde de tres segmentos como vectores de vacunas. | |
| MX2020000221A (es) | Secuencias de aminoacidos y de acidos nucleicos de adenovirus de grandes simios no humanos, vectores que contienen las mismas y usos de las mismas. | |
| MX2015005505A (es) | Vacunas basadas en particular recombinantes contra la infeccion de citomegalovirus humano. | |
| CN104379733A (zh) | 具改变末端的重组腺病毒群 | |
| JP2012025784A5 (enExample) | ||
| JP2012065652A5 (enExample) | ||
| Liu et al. | An optimized circular polymerase extension reaction-based method for functional analysis of SARS-CoV-2 | |
| JP2013507935A5 (enExample) | ||
| JP2016533172A5 (enExample) | ||
| BR112015006763B1 (pt) | Constructo de ácido nucleico, vetor de transferência plasmídico, partículas de vírus mv-chik, composições, uso da composição, uso das partículas de vírus mv-chik e processo para resgatar vírus do sarampo (mv) recombinante | |
| JP2013515473A5 (enExample) | ||
| Luo et al. | A rapid strategy for constructing novel simian adenovirus vectors with high viral titer and expressing highly antigenic proteins applicable for vaccine development | |
| SG10201810846WA (en) | Cold-adapted-viral-attenuation (cava) and novel attenuated poliovirus strains | |
| WO2012116253A3 (en) | Recombinant mumps virus vaccine | |
| CN107523555A (zh) | 获得病毒的方法 | |
| Yang et al. | Rapid, efficient, and modular generation of adenoviral vectors via isothermal assembly | |
| CL2013002723A1 (es) | Metodo de produccion de una particula semejante a virus (vlp) de alfavirus salmonido (sav) en celulas de insecto. | |
| JP2012125257A5 (enExample) | ||
| Lan et al. | Isolation of novel simian adenoviruses from macaques for development of a vector for human gene therapy and vaccines | |
| RU2013110786A (ru) | Постоянные линии клеток человека для получения вирусов гриппа | |
| Zhu et al. | Inhibition of porcine reproductive and respiratory syndrome virus replication with exosome-transferred artificial microRNA targeting the 3′ untranslated region |